Cytotoxicity comparison of 35 developmental neurotoxicants in human induced pluripotent stem cells (iPSC), iPSC-derived neural progenitor cells, and transformed cell lines

被引:8
|
作者
Kamata, Shotaro [1 ]
Hashiyama, Reina [1 ]
Hana-ika, Hiroto [1 ]
Ohkubo, Issei [1 ]
Saito, Ryota [1 ]
Honda, Akihiro [1 ]
Anan, Yasumi [1 ]
Akahoshi, Noriyuki [1 ]
Noguchi, Kohji [2 ]
Kanda, Yasunari [3 ]
Ishii, Isao [1 ]
机构
[1] Showa Pharmaceut Univ, Dept Hlth Chem, Machida, Tokyo 1948543, Japan
[2] Tokyo Univ Sci, Fac Pharmaceut Sci, Lab Mol Target Therapy, Noda, Chiba 2788510, Japan
[3] Natl Inst Hlth Sci, Div Pharmacol, Kawasaki, Kanagawa 2109501, Japan
关键词
Developmental neurotoxicity; Induced pluripotent stem cell; Neural differentiation; Cytotoxicity; Preclinical test; Cell viability assay; HOMEOBOX GENE OTX2; NERVOUS-SYSTEM; EXPOSURE; MOUSE; CHLORPYRIFOS; MICROTUBULE; GENERATION; INDUCTION; CHILDREN;
D O I
10.1016/j.tiv.2020.104999
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The Organization for Economic Co-operation and Development (OECD) test guideline 426 for developmental neurotoxicity (DNT) of industrial/environmental chemicals depends primarily on animal experimentation. This requirement raises various critical issues, such as high cost, long duration, the sacrifice of large numbers of animals, and interspecies differences. This study demonstrates an alternative protocol that is simple, quick, less expensive, and standardized to evaluate DNT of many chemicals using human induced pluripotent stem cells (iPSC) and their differentiation to neural progenitor cells (NPC). Initially, concentration-dependent cytotoxicity of 35 DNT chemicals, including industrial materials, insecticides, and clinical drugs, were compared among iPSC, NPC, and two transformed cells, Cos-7 and HepG2, using tetrazolium dye (MTS)-reducing colorimetric and ATP luciferase assays, and IC50 values were calculated. Next, inhibitory effects of the 14 representative chemicals (mainly insecticides) on iPSC differentiation to NPC were evaluated by measuring altered expression of neural differentiation and undifferentiation marker genes. Results show that both iPSC and NPC were much more sensitive to most DNT chemicals than the transformed cells, and 14 chemicals induced differential patterns of marker gene expression, highlighting the validity and utility of the protocol for evaluation and classification of DNT chemicals and preclinical DNT tests for safety assessment.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Regenerative therapy for vestibular disorders using human induced pluripotent stem cells (iPSCs): neural differentiation of human iPSC-derived neural stem cells after in vitro transplantation into mouse vestibular epithelia
    Taura, Akiko
    Nakashima, Noriyuki
    Ohnishi, Hiroe
    Nakagawa, Takayuki
    Funabiki, Kazuo
    Ito, Juichi
    Omori, Koichi
    ACTA OTO-LARYNGOLOGICA, 2016, 136 (10) : 999 - 1005
  • [22] Pathological classification of human iPSC-derived neural stem/progenitor cells towards safety assessment of transplantation therapy for CNS diseases
    Sugai, Keiko
    Fukuzawa, Ryuji
    Shofuda, Tomoko
    Fukusumi, Hayato
    Kawabata, Soya
    Nishiyama, Yuichiro
    Higuchi, Yuichiro
    Kawai, Kenji
    Isoda, Miho
    Kanematsu, Daisuke
    Hashimoto-Tamaoki, Tomoko
    Kohyama, Jun
    Iwanami, Akio
    Suemizu, Hiroshi
    Ikeda, Eiji
    Matsumoto, Morio
    Kanemura, Yonehiro
    Nakamura, Masaya
    Okano, Hideyuki
    MOLECULAR BRAIN, 2016, 9
  • [23] Pathological classification of human iPSC-derived neural stem/progenitor cells towards safety assessment of transplantation therapy for CNS diseases
    Keiko Sugai
    Ryuji Fukuzawa
    Tomoko Shofuda
    Hayato Fukusumi
    Soya Kawabata
    Yuichiro Nishiyama
    Yuichiro Higuchi
    Kenji Kawai
    Miho Isoda
    Daisuke Kanematsu
    Tomoko Hashimoto-Tamaoki
    Jun Kohyama
    Akio Iwanami
    Hiroshi Suemizu
    Eiji Ikeda
    Morio Matsumoto
    Yonehiro Kanemura
    Masaya Nakamura
    Hideyuki Okano
    Molecular Brain, 9
  • [24] An Alternative Cell Therapy for Cancers: Induced Pluripotent Stem Cell (iPSC)-Derived Natural Killer Cells
    Hsu, Li-Jie
    Liu, Chao-Lin
    Kuo, Ming-Ling
    Shen, Chia-Ning
    Shen, Chia-Rui
    BIOMEDICINES, 2021, 9 (10)
  • [25] Reference Gene Validation via RT–qPCR for Human iPSC-Derived Neural Stem Cells and Neural Progenitors
    Justyna Augustyniak
    Jacek Lenart
    Gabriela Lipka
    Piotr P. Stepien
    Leonora Buzanska
    Molecular Neurobiology, 2019, 56 : 6820 - 6832
  • [26] Morphological Characterization of Astrocytes in a Xenograft of Human iPSC-Derived Neural Precursor Cells
    Voronkov, D. N.
    Stavrovskaya, A. V.
    Guschina, A. S.
    Olshansky, A. S.
    Lebedeva, O. S.
    Lagarkova, M. A.
    Eremeev, A. V.
    ACTA NATURAE, 2022, 14 (03): : 100 - 108
  • [27] Functional efficacy of transplanted, iPSC-derived, human neural stem cells in the brains of MPS I mice
    Calhoun, Caitlin
    Kan, Shih-Hsin
    Stover, Alexander E.
    Harb, Jerry
    Monuki, Edwin S.
    Torres, Evelyn
    Schwartz, Philip
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [28] Generation of Human iPSC-derived Neural Progenitor Cells (NPCs) as Drug Discovery Model for Neurological and Mitochondrial Disorders
    Zink, Annika
    Lisowski, Pawel
    Prigione, Alessandro
    BIO-PROTOCOL, 2021, 11 (05):
  • [29] AN ACTIVATED GPR56 RECEPTOR ENHANCES SURVIVAL OF HUMAN IPSC-DERIVED HAEMATOPOIETIC STEM/ PROGENITOR CELLS
    Dzierzak, Elaine Anne
    Mackintosh, Lorna
    Maglitto, Antonio
    Seoane, Carmen Rodriguez
    Mariani, Samanta
    Crisan, Mihaela
    Vink, Chris
    Popravko, Anna
    Rossi, Adriano
    EXPERIMENTAL HEMATOLOGY, 2024, 137
  • [30] Investigating neural differentiation capacity in Alzheimer's disease iPSC-derived neural stem cells
    Burrows, A.
    McKay, T. R.
    HUMAN GENE THERAPY, 2019, 30 (11) : A130 - A130